Lung Cancer in Never Smokers

• Parkin DM , PisaniP, FerlayJ. Estimates of the worldwide incidence of eighteen major cancers in 1985.Int. J. Cancer54(4), 594–606 (1993).
   PubMed Web of Science ®Google Scholar
• Ferlay J , ShinHR, BrayF, FormanD, MathersC, ParkinDM. Estimates of worldwide burden of cancer in 2008. GLOBOCAN 2008.Int. J. Cancer127(12), 2893–2917
   PubMed Web of Science ®Google Scholar
• Parkin DM , BrayF, FerlayJ, PisaniP. Global cancer statistics, 2002.CA Cancer J. Clin.55(2), 74–108 (2005).
   PubMed Web of Science ®Google Scholar
• WHO . The Demographics of Tobacco. WHO, 94–101 (2011).
   Google Scholar
• Sun S , SchillerJH, GazdarAF. Lung cancer in never smokers – a different disease.Nat. Rev. Cancer7(10), 778–790 (2007).
   PubMed Web of Science ®Google Scholar
• Yano T , MiuraN, TakenakaTet al. Never-smoking non-small cell lung cancer as a separate entity. clinicopathologic features and survival. Cancer 113(5), 1012–1018 (2008).
   PubMed Web of Science ®Google Scholar
• Boffetta P , JarvholmB, BrennanP, NyrenO. Incidence of lung cancer in a large cohort of nonsmoking men from Sweden.Int. J. Cancer94(4), 591–593 (2001).
   PubMed Web of Science ®Google Scholar
• Thun MJ , HenleySJ, BurnsD, JemalA, ShanksTG, CalleEE. Lung cancer death rates in lifelong nonsmokers.J. Natl Cancer Inst.98(10), 691–699 (2006).
   PubMedGoogle Scholar
• Yano T , HaroA, ShikadaY, MaruyamaR, MaeharaY. Non-small cell lung cancer in never smokers as a representative ‘nonsmoking-associated lung cancer’. epidemiology and clinical features.Int. J. Clin. Oncol.16(4), 287–293 (2011).
   PubMed Web of Science ®Google Scholar
• Scagliotti GV , LongoM, NovelloS. Non-small cell lung cancer in never smokers.Curr. Opin Oncol.21(2), 99–104 (2009).
   PubMed Web of Science ®Google Scholar
• Lee YJ , KimJH, KimSKet al. Lung cancer in never smokers. change of a mindset in the molecular era. Lung Cancer 72, 9–15 (2011).
   PubMed Web of Science ®Google Scholar
• Jindal SK , MalikSK, DhandR, GujralJS, MalikAK, DattaBN. Bronchogenic carcinoma in Northern India.Thorax37(5), 343–347 (1982).
   PubMed Web of Science ®Google Scholar
• Badar F , MeerzaF, KhokharRAet al. Characteristics of lung cancer patients – the Shaukat Khanum Memorial experience. Asian Pac. J. Cancer Prev. 7(2), 245–248 (2006).
   PubMedGoogle Scholar
• Henschke CI , MiettinenOS. Women’s susceptibility to tobacco carcinogens.Lung Cancer43(1), 1–5 (2004).
   PubMed Web of Science ®Google Scholar
• Henschke CI , YipR, MiettinenOS. Women’s susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer.JAMA296(2), 180–184 (2006).
   PubMed Web of Science ®Google Scholar
• Taioli E , CroftsF, TrachmanJ, DemopoulosR, TonioloP, GarteSJ. A specific African–American CYP1A1 polymorphism is associated with adenocarcinoma of the lung.Cancer Res.55(3), 472–473 (1995).
   PubMed Web of Science ®Google Scholar
• Coté ML , KardiaSL, WenzlaffAS, RuckdeschelJC, SchwartzAG. Risk of lung cancer among white and black relatives of individuals with early-onset lung cancer.JAMA293(24), 3036–3042 (2005).
   PubMed Web of Science ®Google Scholar
• London SJ , DalyAK, FairbrotherKSet al. Lung cancer risk in African–Americans in relation to a race-specific CYP1A1 polymorphism. Cancer Res. 55(24), 6035–6037 (1995).
   PubMed Web of Science ®Google Scholar
• Thun MJ , HannanLM, Adams-CampbellLLet al. Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS Med. 5(9), e185 (2008).
   PubMed Web of Science ®Google Scholar
• Hong KU , ReynoldsSD, WatkinsS, FuchsE, StrippBR. Basal cells are a multipotent progenitor capable of renewing the bronchial epithelium.Am. J. Pathol.164(2), 577–588 (2004).
   PubMed Web of Science ®Google Scholar
• Coulson JM , Ocejo-GarciaM, WollPJ. Neuroendocrine phenotype of small cell lung cancer.Methods Mol. Med.74, 61–73 (2003).
   PubMedGoogle Scholar
• Lassen U , OsterlindK, HansenM, DombernowskyP, BergmanB, HansenHH. Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years – an analysis of 1,714 consecutive patients.J. Clin. Oncol.13(5), 1215–1220 (1995).
   PubMed Web of Science ®Google Scholar
• Yokota J , ShiraishiK, KohnoT. Genetic basis for susceptibility to lung cancer: recent progress and future directions.Adv. Cancer Res.109, 51–72 (2010)
   PubMed Web of Science ®Google Scholar
• Zheng B , ZhouJ, GengQ, DongQ. A preliminary study on the origin of human lung adenocarcinoma stem cells from lung bonchioalveolar stem cells.Zhongguo Fei Ai Za Zhi11(6), 759–764 (2008).
   PubMedGoogle Scholar
• Yatabe Y , KosakaT, TakahashiT, MitsudomiT. EGFR mutation is specific for terminal respiratory unit type adenocarcinoma.Am. J. Surg. Pathol.29(5), 633–639 (2005).
   PubMed Web of Science ®Google Scholar
• Huxley R , JamrozikK, LamTHet al. Impact of smoking and smoking cessation on lung cancer mortality in the Asia–Pacific region. Am. J. Epidemiol. 165(11), 1280–1286 (2007).
   PubMed Web of Science ®Google Scholar
• Bae JM , LeeMS, ShinMH, KimDH, LiZM, AhnYO. Cigarette smoking and risk of lung cancer in Korean men: the Seoul Male Cancer Cohort Study.J. Korean Med. Sci.22(3), 508–512 (2007).
   PubMed Web of Science ®Google Scholar
• Stellman SD , TakezakiT, WangLet al. Smoking and lung cancer risk in American and Japanese men: an international case–control study. Cancer Epidemiol. Biomarkers Prev. 10(11), 1193–1199 (2001).
   PubMed Web of Science ®Google Scholar
• Brownson RC , AlavanjaMC, CaporasoN, SimoesEJ, ChangJC. Epidemiology and prevention of lung cancer in nonsmokers.Epidemiol. Rev.20(2), 218–236 (1998).
   PubMed Web of Science ®Google Scholar
• Maclure M , KatzRB, BryantMS, SkipperPL, TannenbaumSR. Elevated blood levels of carcinogens in passive smokers.Am. J. Public Health79(10), 1381–1384 (1989).
   PubMed Web of Science ®Google Scholar
• Crawford FG , MayerJ, SantellaRMet al. Biomarkers of environmental tobacco smoke in preschool children and their mothers. J. Natl Cancer Inst. 86(18), 1398–1402 (1994).
   PubMed Web of Science ®Google Scholar
• Subramanian J , GovindanR. Lung cancer in ‘Never-smokers’: a unique entity.Oncology (Williston Park)24(1), 29–35 (2010).
   PubMed Web of Science ®Google Scholar
• Samet JM , Avila-TangE, BoffettaPet al. Lung cancer in never smokers: clinical epidemiology and environmental risk factors. Clin. Cancer Res. 15(18), 5626–5645 (2009).
   PubMed Web of Science ®Google Scholar
• International Agency for Research on Cancer. Tobacco smoking and involuntary smoking. IARC monographs on the evaluation of carcinogenic risks to humans. IARC Press, Lyon, France83 (2004).
   Google Scholar
• Vineis P , AlavanjaM, BufflerPet al. Tobacco and cancer: recent epidemiological evidence. J. Natl Cancer Inst. 96(2), 99–106 (2004).
   PubMedGoogle Scholar
• Hackshaw AK , LawMR, WaldNJ. The accumulated evidence on lung cancer and environmental tobacco smoke.BMJ315(7114), 980–988 (1997).
   PubMed Web of Science ®Google Scholar
• Kurahashi N , InoueM, LiuYet al. Passive smoking and lung cancer in Japanese nonsmoking women: a prospective study. Int. J. Cancer 122(3), 653–657 (2008).
   PubMed Web of Science ®Google Scholar
• Gilliland FD , HuntWC, ArcherVE, SaccomannoG. Radon progeny exposure and lung cancer risk among nonsmoking uranium miners.Health Phys.79(4), 365–372 (2000).
   PubMed Web of Science ®Google Scholar
• Samet JM , KutvirtDM, WaxweilerRJ, KeyCR. Uranium mining and lung cancer in Navajo men.N. Engl. J. Med.310(23), 1481–1484 (1984).
   PubMed Web of Science ®Google Scholar
• Roscoe RJ , DeddensJA, SalvanA, SchnorrTM. Mortality among Navajo uranium miners.Am. J. Public Health85(4), 535–540 (1995).
   PubMed Web of Science ®Google Scholar
• Roscoe RJ , SteenlandK, HalperinWE, BeaumontJJ, WaxweilerRJ. Lung cancer mortality among nonsmoking uranium miners exposed to radon daughters.JAMA262(5), 629–633 (1989).
   PubMed Web of Science ®Google Scholar
• Belinsky SA , KlingeDM, LiechtyKCet al. Plutonium targets the p16 gene for inactivation by promoter hypermethylation in human lung adenocarcinoma. Carcinogenesis 25(6), 1063–1067 (2004).
   PubMed Web of Science ®Google Scholar
• Samet JM . Radon and lung cancer.J. Natl Cancer Inst.81(10), 745–757 (1989).
   PubMedGoogle Scholar
• Krewski D , LubinJH, ZielinskiJMet al. A combined analysis of North American case–control studies of residential radon and lung cancer. J. Toxicol. Environ Health A 69(7), 533–597 (2006).
   PubMed Web of Science ®Google Scholar
• Lubin JH , BoiceJDJr, EdlingCet al. Lung cancer in radon-exposed miners and estimation of risk from indoor exposure. J. Natl Cancer Inst. 87(11), 817–827 (1995).
   PubMedGoogle Scholar
• Darby S , HillD, AuvinenAet al. Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case–control studies. BMJ 330(7485), 223 (2005).
   PubMed Web of Science ®Google Scholar
• Carbone M , KratzkeRA, TestaJR. The pathogenesis of mesothelioma.Semin. Oncol.29(1), 2–17 (2002).
   PubMed Web of Science ®Google Scholar
• Mossman BT , BignonJ, CornM, SeatonA, GeeJB. Asbestos: scientific developments and implications for public policy.Science247(4940), 294–301 (1990).
   PubMed Web of Science ®Google Scholar
• Reid A , DE KlerkNH, AmbrosiniGL, BerryG, MuskAW. The risk of lung cancer with increasing time since ceasing exposure to asbestos and quitting smoking.Occup. Environ. Med.63(8), 509–512 (2006).
   PubMed Web of Science ®Google Scholar
• Camus M , SiemiatyckiJ, MeekB. Nonoccupational exposure to chrysotile asbestos and the risk of lung cancer.N. Engl. J. Med.338(22), 1565–1571 (1998).
   PubMed Web of Science ®Google Scholar
• Reid A , HeyworthJ, De KlerkN, MuskAW. The mortality of women exposed environmentally and domestically to blue asbestos at Wittenoom, Western Australia.Occup. Environ. Med.65(11), 743–749 (2008).
   PubMed Web of Science ®Google Scholar
• Li S , PanD, WangG. Analysis of polycyclic aromatic hydrocarbons in cooking oil fumes.Arch. Environ. Health49(2), 119–122 (1994).
   PubMedGoogle Scholar
• Shields PG , XuGX, BlotWJet al. Mutagens from heated Chinese and U.S. cooking oils. J. Natl Cancer Inst. 87(11), 836–841 (1995).
   PubMed Web of Science ®Google Scholar
• Chiang TA , WuPF, WangLF, LeeH, LeeCH, KoYC. Mutagenicity and polycyclic aromatic hydrocarbon content of fumes from heated cooking oils produced in Taiwan.Mutat. Res.381(2), 157–161 (1997).
   PubMed Web of Science ®Google Scholar
• Yang SC , JenqSN, KangZC, LeeH. Identification of benzo[α]pyrene 7,8-diol 9,10-epoxide N2-deoxyguanosine in human lung adenocarcinoma cells exposed to cooking oil fumes from frying fish under domestic conditions.Chem. Res. Toxicol.13(10), 1046–1050 (2000).
   PubMed Web of Science ®Google Scholar
• Yu IT , ChiuYL, AuJS, WongTW, TangJL. Dose–response relationship between cooking fumes exposures and lung cancer among Chinese nonsmoking women.Cancer Res.66(9), 4961–4967 (2006).
   PubMed Web of Science ®Google Scholar
• Ko YC , ChengLS, LeeCHet al. Chinese food cooking and lung cancer in women nonsmokers. Am. J. Epidemiol. 151(2), 140–147 (2000).
   PubMed Web of Science ®Google Scholar
• Kleinerman R , WangZ, LubinJ, ZhangS, MetayerC, BrennerA. Lung cancer and indoor air pollution in rural china.Ann. Epidemiol.10(7), 469 (2000).
   PubMedGoogle Scholar
• Zhong L , GoldbergMS, GaoYT, JinF. Lung cancer and indoor air pollution arising from Chinese-style cooking among nonsmoking women living in Shanghai, China.Epidemiology10(5), 488–494 (1999).
   PubMed Web of Science ®Google Scholar
• Seow A , PohWT, TehMet al. Fumes from meat cooking and lung cancer risk in Chinese women. Cancer Epidemiol. Biomarkers Prev. 9(11), 1215–1221 (2000).
   PubMed Web of Science ®Google Scholar
• Zhao Y , WangS, AunanK, SeipHM, HaoJ. Air pollution and lung cancer risks in China – a meta-analysis.Sci. Total Environ.366(2–3), 500–513 (2006).
   PubMed Web of Science ®Google Scholar
• Metayer C , WangZ, KleinermanRAet al. Cooking oil fumes and risk of lung cancer in women in rural Gansu, China. Lung Cancer 35(2), 111–117 (2002).
   PubMed Web of Science ®Google Scholar
• Rehfuess E , MehtaS, Pruss-UstunA. Assessing household solid fuel use: multiple implications for the Millennium Development Goals.Environ. Health Perspect.114(3), 373–378 (2006).
   PubMed Web of Science ®Google Scholar
• Lan Q , ChapmanRS, SchreinemachersDM, TianL, HeX. Household stove improvement and risk of lung cancer in Xuanwei, China.J. Natl Cancer Inst.94(11), 826–835 (2002).
   PubMed Web of Science ®Google Scholar
• Mumford JL , HeXZ, ChapmanRSet al. Lung cancer and indoor air pollution in Xuan Wei, China. Science 235(4785), 217–220 (1987).
   PubMed Web of Science ®Google Scholar
• Sapkota A , GajalakshmiV, JetlyDHet al. Indoor air pollution from solid fuels and risk of hypopharyngeal/laryngeal and lung cancers: a multicentric case–control study from India. Int. J. Epidemiol. 37(2), 321–328 (2008).
   PubMed Web of Science ®Google Scholar
• Luo RX , WuB, YiYN, HuangZW, LinRT. Indoor burning coal air pollution and lung cancer – a case–control study in Fuzhou, China.Lung Cancer14(Suppl. 1), S113–S119 (1996).
   PubMedGoogle Scholar
• Zhou BS , WangTJ, GuanP, WuJM. Indoor air pollution and pulmonary adenocarcinoma among females: a case–control study in Shenyang, China.Oncol. Rep.7(6), 1253–1259 (2000).
   PubMed Web of Science ®Google Scholar
• Dai XD , LinCY, SunXW, ShiYB, LinYJ. The etiology of lung cancer in nonsmoking females in Harbin, China.Lung Cancer14(Suppl. 1), S85–S91 (1996).
   PubMedGoogle Scholar
• Besso A , NybergF, PershagenG. Air pollution and lung cancer mortality in the vicinity of a nonferrous metal smelter in Sweden.Int. J. Cancer107(3), 448–452 (2003).
   PubMed Web of Science ®Google Scholar
• Zeka A , MannetjeA, ZaridzeDet al. Lung cancer and occupation in nonsmokers: a multicenter case–control study in Europe. Epidemiology 17(6), 615–623 (2006).
   PubMed Web of Science ®Google Scholar
• Ko YC , LeeCH, ChenMJet al. Risk factors for primary lung cancer among nonsmoking women in Taiwan. Int. J. Epidemiol. 26(1), 24–31 (1997).
   PubMed Web of Science ®Google Scholar
• Sobue T . Association of indoor air pollution and lifestyle with lung cancer in Osaka, Japan.Int. J. Epidemiol.19(Suppl. 1), S62–S66 (1990).
   PubMedGoogle Scholar
• Hernandez-Garduno E , BrauerM, Perez-NeriaJ, VedalS. Wood smoke exposure and lung adenocarcinoma in nonsmoking Mexican women.Int. J. Tuberc. Lung Dis.8(3), 377–383 (2004).
   PubMed Web of Science ®Google Scholar
• Behera D , BalamugeshT. Indoor air pollution as a risk factor for lung cancer in women.J. Assoc. Physicians India53, 190–192 (2005).
   PubMedGoogle Scholar
• Brenner DR , MclaughlinJR, HungRJ. Previous lung diseases and lung cancer risk: a systematic review and meta-analysis.PLoS ONE6(3), E17479 (2011).
   PubMed Web of Science ®Google Scholar
• Schabath MB , DelclosGL, MartynowiczMMet al. Opposing effects of emphysema, hay fever, and select genetic variants on lung cancer risk. Am. J. Epidemiol. 161(5), 412–422 (2005).
   PubMed Web of Science ®Google Scholar
• Brenner DR , HungRJ, TsaoMSet al. Lung cancer risk in never-smokers: a population-based case–control study of epidemiologic risk factors. BMC Cancer 10, 285 (2010).
   PubMed Web of Science ®Google Scholar
• Santillan AA , CamargoCAJr, ColditzGA. A meta-analysis of asthma and risk of lung cancer (United States).Cancer Causes Control14(4), 327–334 (2003).
   PubMed Web of Science ®Google Scholar
• Seow A , NgDP, ChooSet al. Joint effect of asthma/atopy and an IL-6 gene polymorphism on lung cancer risk among lifetime nonsmoking Chinese women. Carcinogenesis 27(6), 1240–1244 (2006).
   PubMed Web of Science ®Google Scholar
• Alavanja MC , BrownsonRC, BoiceJDJr, HockE. Preexisting lung disease and lung cancer among nonsmoking women.Am. J. Epidemiol.136(6), 623–632 (1992).
   PubMed Web of Science ®Google Scholar
• Gorlova OY , ZhangY, SchabathMBet al. Never smokers and lung cancer risk: a case–control study of epidemiological factors. Int. J. Cancer 118(7), 1798–1804 (2006).
   PubMed Web of Science ®Google Scholar
• Bauer AK , MalkinsonAM, KleebergerSR. Susceptibility to neoplastic and nonneoplastic pulmonary diseases in mice: genetic similarities.Am. J. Physiol. Lung Cell Mol. Physiol.287(4), L685–L703 (2004).
   PubMed Web of Science ®Google Scholar
• Hinds MW , CohenHI, KolonelLN. Tuberculosis and lung cancer risk in nonsmoking women.Am. Rev. Respir. Dis.125(6), 776–778 (1982).
   PubMedGoogle Scholar
• Zheng W , BlotWJ, LiaoMLet al. Lung cancer and prior tuberculosis infection in Shanghai. Br. J. Cancer 56(4), 501–504 (1987).
   PubMed Web of Science ®Google Scholar
• Hubbard R , VennA, LewisS, BrittonJ. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study.Am. J. Respir. Crit. Care Med.161(1), 5–8 (2000).
   PubMed Web of Science ®Google Scholar
• Wells C , ManninoDM. Pulmonary fibrosis and lung cancer in the United States: analysis of the multiple cause of death mortality data, 1979 through 1991.South Med. J.89(5), 505–510 (1996).
   PubMed Web of Science ®Google Scholar
• Ganti AK , SahmounAE, PanwalkarAW, TendulkarKK, PottiA. Hormone replacement therapy is associated with decreased survival in women with lung cancer.J. Clin. Oncol.24(1), 59–63 (2006).
   PubMed Web of Science ®Google Scholar
• Schabath MB , WuX, Vassilopoulou-SellinR, VaporciyanAA, SpitzMR. Hormone replacement therapy and lung cancer risk: a case–control analysis.Clin. Cancer Res.10(1 Pt 1), 113–123 (2004).
   PubMed Web of Science ®Google Scholar
• Kreuzer M , GerkenM, HeinrichJ, KreienbrockL, WichmannHE. Hormonal factors and risk of lung cancer among women?Int. J. Epidemiol.32(2), 263–271 (2003).
   PubMed Web of Science ®Google Scholar
• Blackman JA , CooganPF, RosenbergLet al. Estrogen replacement therapy and risk of lung cancer. Pharmacoepidemiol. Drug Saf. 11(7), 561–567 (2002).
   PubMed Web of Science ®Google Scholar
• Schwartz AG , WenzlaffAS, PrysakGMet al. Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women. J. Clin. Oncol. 25(36), 5785–5792 (2007).
   PubMed Web of Science ®Google Scholar
• Fasco MJ , HurteauGJ, SpivackSD. Gender-dependent expression of α and β estrogen receptors in human nontumor and tumor lung tissue.Mol. Cell Endocrinol.188(1–2), 125–140 (2002).
   PubMed Web of Science ®Google Scholar
• Schwartz AG , PrysakGM, MurphyVet al. Nuclear estrogen receptor β in lung cancer: expression and survival differences by sex. Clin. Cancer Res. 11(20), 7280–7287 (2005).
   PubMed Web of Science ®Google Scholar
• Wu CT , ChangYL, ShihJY, LeeYC. The significance of estrogen receptor β in 301 surgically treated non-small cell lung cancers.J. Thorac. Cardiovasc. Surg.130(4), 979–986 (2005).
   PubMed Web of Science ®Google Scholar
• Kawai H , IshiiA, WashiyaKet al. Estrogen receptor α and β are prognostic factors in non-small cell lung cancer. Clin. Cancer Res. 11(14), 5084–5089 (2005).
   PubMed Web of Science ®Google Scholar
• Hershberger PA , VasquezAC, KanterewiczB, LandS, SiegfriedJM, NicholsM. Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands.Cancer Res.65(4), 1598–1605 (2005).
   PubMed Web of Science ®Google Scholar
• Yager JD , LiehrJG. Molecular mechanisms of estrogen carcinogenesis.Annu. Rev. Pharmacol. Toxicol.36, 203–232 (1996).
   PubMed Web of Science ®Google Scholar
• Cavalieri E , RoganE. Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture.Ann. NY Acad. Sci.1089, 286–301 (2006).
   PubMed Web of Science ®Google Scholar
• Stabile LP , LykerJS, GubishCT, ZhangW, GrandisJR, SiegfriedJM. Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects.Cancer Res.65(4), 1459–1470 (2005).
   PubMed Web of Science ®Google Scholar
• Niikawa H , SuzukiT, MikiYet al. Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma. Clin. Cancer Res. 14(14), 4417–4426 (2008).
   PubMed Web of Science ®Google Scholar
• Cheng YW , ChiouHL, SheuGTet al. The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res. 61(7), 2799–2803 (2001).
   PubMed Web of Science ®Google Scholar
• Syrjanen KJ . HPV infections and lung cancer.J. Clin. Pathol.55(12), 885–891 (2002).
   PubMed Web of Science ®Google Scholar
• Bohlmeyer T , LeTN, ShroyerAL, MarkhamN, ShroyerKR. Detection of human papillomavirus in squamous cell carcinomas of the lung by polymerase chain reaction.Am. J. Respir. Cell Mol. Biol.18(2), 265–269 (1998).
   PubMed Web of Science ®Google Scholar
• Chen YC , ChenJH, RichardK, ChenPY, ChristianiDC. Lung adenocarcinoma and human papillomavirus infection.Cancer101(6), 1428–1436 (2004).
   PubMed Web of Science ®Google Scholar
• Subramanian J , GovindanR. Lung cancer in never smokers: a review.J. Clin. Oncol.25(5), 561–570 (2007).
   PubMed Web of Science ®Google Scholar
• Engels EA , BrockMV, ChenJ, HookerCM, GillisonM, MooreRD. Elevated incidence of lung cancer among HIV-infected individuals.J. Clin. Oncol.24(9), 1383–1388 (2006).
   PubMed Web of Science ®Google Scholar
• Kirk GD , MerloC, O’DriscollPet al. HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin. Infect. Dis. 45(1), 103–110 (2007).
   PubMed Web of Science ®Google Scholar
• Key TJ , AllenNE, SpencerEA, TravisRC. The effect of diet on risk of cancer.Lancet360(9336), 861–868 (2002).
   PubMed Web of Science ®Google Scholar
• Ozasa K , WatanabeY, ItoYet al. Dietary habits and risk of lung cancer death in a large-scale cohort study (JACC Study) in Japan by sex and smoking habit. Jpn J. Cancer Res. 92(12), 1259–1269 (2001).
   PubMedGoogle Scholar
• Koo LC . Dietary habits and lung cancer risk among Chinese females in Hong Kong who never smoked.Nutr. Cancer11(3), 155–172 (1988).
   PubMed Web of Science ®Google Scholar
• Gustavsson P , JakobssonR, NybergF, PershagenG, JarupL, ScheeleP. Occupational exposure and lung cancer risk: a population-based case-referent study in Sweden.Am. J. Epidemiol.152(1), 32–40 (2000).
   PubMed Web of Science ®Google Scholar
• Pierce DA , SharpGB, MabuchiK. Joint effects of radiation and smoking on lung cancer risk among atomic bomb survivors.Radiat. Res.159(4), 511–520 (2003).
   PubMed Web of Science ®Google Scholar
• Richardson DB , WingS, WolfS. Mortality among workers at the Savannah River Site.Am. J. Ind. Med.50(12), 881–891 (2007).
   PubMed Web of Science ®Google Scholar
• Nitadori J , InoueM, IwasakiMet al. Association between lung cancer incidence and family history of lung cancer: data from a large-scale population-based cohort study, the JPHC study. Chest 130(4), 968–975 (2006).
   PubMed Web of Science ®Google Scholar
• Tokuhata GK , LilienfeldAM. Familial aggregation of lung cancer among hospital patients.Public Health Rep.78, 277–283 (1963).
   PubMed Web of Science ®Google Scholar
• Tokuhata GK , LilienfeldAM. Familial aggregation of lung cancer in humans.J. Natl Cancer Inst.30, 289–312 (1963).
   PubMedGoogle Scholar
• Ooi WL , ElstonRC, ChenVW, Bailey-WilsonJE, RothschildH. Increased familial risk for lung cancer.J. Natl Cancer Inst.76(2), 217–222 (1986).
   PubMedGoogle Scholar
• Czene K , LichtensteinP, HemminkiK. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database.Int. J. Cancer99(2), 260–266 (2002).
   PubMed Web of Science ®Google Scholar
• Jonsson S , ThorsteinsdottirU, GudbjartssonDFet al. Familial risk of lung carcinoma in the Icelandic population. JAMA 292(24), 2977–2983 (2004).
   PubMed Web of Science ®Google Scholar
• Schwartz AG , YangP, SwansonGM. Familial risk of lung cancer among nonsmokers and their relatives.Am. J. Epidemiol.144(6), 554–562 (1996).
   PubMed Web of Science ®Google Scholar
• Etzel CJ , AmosCI, SpitzMR. Risk for smoking-related cancer among relatives of lung cancer patients.Cancer Res.63(23), 8531–8535 (2003).
   PubMed Web of Science ®Google Scholar
• Brownson RC , AlavanjaMC, CaporasoN, BergerE, ChangJC. Family history of cancer and risk of lung cancer in lifetime nonsmokers and long-term ex-smokers.Int. J. Epidemiol.26(2), 256–263 (1997).
   PubMed Web of Science ®Google Scholar
• Matakidou A , EisenT, HoulstonRS. Systematic review of the relationship between family history and lung cancer risk.Br. J. Cancer93(7), 825–833 (2005).
   PubMed Web of Science ®Google Scholar
• Amos CI , WuX, BroderickPet al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat. Genet. 40(5), 616–622 (2008).
   PubMed Web of Science ®Google Scholar
• Kohno T , KunitohH, ShimadaYet al. Individuals susceptible to lung adenocarcinoma defined by combined HLA-DQA1 and TERT genotypes. Carcinogenesis 31(5), 834–841 (2010).
   PubMed Web of Science ®Google Scholar
• Landi MT , ChatterjeeN, YuKet al. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am. J. Hum. Genet. 85(5), 679–691 (2009).
   PubMed Web of Science ®Google Scholar
• Wang Y , BroderickP, WebbEet al. Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat. Genet. 40(12), 1407–1409 (2008).
   PubMed Web of Science ®Google Scholar
• Li Y , SheuCC, YeYet al. Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. Lancet Oncol. 11(4), 321–330 (2010).
   PubMed Web of Science ®Google Scholar
• You M , WangD, LiuPet al. Fine mapping of chromosome 6q23–25 region in familial lung cancer families reveals RGS17 as a likely candidate gene. Clin. Cancer Res. 15(8), 2666–2674 (2009).
   PubMed Web of Science ®Google Scholar
• Liu P , VikisHg, LuYet al. Cumulative effect of multiple loci on genetic susceptibility to familial lung cancer. Cancer Epidemiol. Biomarkers Prev. 19(2), 517–524 (2010).
   PubMed Web of Science ®Google Scholar
• Hung RJ , BoffettaP, BrockmollerJet al. CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian nonsmokers: a pooled analysis. Carcinogenesis 24(5), 875–882 (2003).
   PubMed Web of Science ®Google Scholar
• Yoon KA , KimJH, GilHJ, HwangH, HwangboB, LeeJS. CYP1B1, CYP1A1, MPO, and GSTP1 polymorphisms and lung cancer risk in never-smoking Korean women.Lung Cancer60(1), 40–46 (2008).
   PubMed Web of Science ®Google Scholar
• Kiyohara C , WakaiK, MikamiH, SidoK, AndoM, OhnoY. Risk modification by CYP1A1 and GSTM1 polymorphisms in the association of environmental tobacco smoke and lung cancer: a case–control study in Japanese nonsmoking women.Int. J. Cancer107(1), 139–144 (2003).
   PubMed Web of Science ®Google Scholar
• Bennett WP , AlavanjaMC, BlomekeBet al. Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women. J. Natl Cancer Inst. 91(23), 2009–2014 (1999).
   PubMedGoogle Scholar
• Gorlova OY , WengSF, ZhangY, AmosCI, SpitzMR, WeiQ. DNA repair capacity and lung cancer risk in never smokers.Cancer Epidemiol. Biomarkers Prev.17(6), 1322–1328 (2008).
   PubMed Web of Science ®Google Scholar
• An Y , JinG, WangHet al. Polymorphisms in hMLH1 and risk of early-onset lung cancer in a southeast Chinese population. Lung Cancer 59(2), 164–170 (2008).
   PubMed Web of Science ®Google Scholar
• Fan LH , ChenJL, CaiL. Study on the association between DNA double-strand break repair gene NBS1 polymorphisms and susceptibility on lung cancer.Zhonghua Liu Xing Bing Xue Za Zhi31(2), 213–217 (2010).
   PubMedGoogle Scholar
• Osawa K , MiyaishiA, UchinoKet al. APEX1 Asp148Glu gene polymorphism is a risk factor for lung cancer in relation to smoking in Japanese. Asian Pac. J. Cancer Prev. 11(5), 1181–1186 (2010).
   PubMedGoogle Scholar
• Qian B , ZhangH, ZhangL, ZhouX, YuH, ChenK. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk.Lung Cancer73(2), 138–146 (2010).
   PubMed Web of Science ®Google Scholar
• Zienolddiny S , CampaD, LindHet al. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 27(3), 560–567 (2006).
   PubMed Web of Science ®Google Scholar
• Ryk C , KumarR, ThirumaranRK, HouSM. Polymorphisms in the DNA repair genes XRCC1, APEX1, XRCC3 and NBS1, and the risk for lung cancer in never- and ever-smokers.Lung Cancer54(3), 285–292 (2006).
   PubMed Web of Science ®Google Scholar
• Zhou W , LiuG, MillerDPet al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. Cancer Epidemiol. Biomarkers Prev. 12(4), 359–365 (2003).
   PubMed Web of Science ®Google Scholar
• Lo YL , HsiaoCF, JouYSet al. Polymorphisms of MLH1 and MSH2 genes and the risk of lung cancer among never smokers. Lung Cancer 72(3), 280–286 (2010).
   PubMed Web of Science ®Google Scholar
• Thu KL , ChariR, ZhangWet al. Lung cancer genomes of smokers and never smokers harbor differential regions of copy number alteration. Presented at: AACR Frontiers in Cancer Prevention Research International Conference. Philadelphia, PA, USA, 7–10 November 2010.
   Google Scholar
• Matsuo K , ItoH, YatabeYet al. Risk factors differ for non-small-cell lung cancers with and without EGFR mutation: assessment of smoking and sex by a case–control study in Japanese. Cancer Sci. 98(1), 96–101 (2007).
   PubMed Web of Science ®Google Scholar
• Shigematsu H , TakahashiT, NomuraMet al. Somatic mutations of the HER2 kinase domain in lung adenocarcinomas. Cancer Res. 65(5), 1642–1646 (2005).
   PubMed Web of Science ®Google Scholar
• Matsumoto S , TakahashiK, IwakawaRet al. Frequent EGFR mutations in brain metastases of lung adenocarcinoma. Int. J. Cancer 119(6), 1491–1494 (2006).
   PubMed Web of Science ®Google Scholar
• Pham D , KrisMG, RielyGJet al. Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas. J. Clin. Oncol. 24(11), 1700–1704 (2006).
   PubMed Web of Science ®Google Scholar
• Lee YJ , ChoBC, JeeSHet al. Impact of environmental tobacco smoke on the incidence of mutations in epidermal growth factor receptor gene in never-smoker patients with non-small-cell lung cancer. J. Clin. Oncol. 28(3), 487–492 (2009).
   PubMed Web of Science ®Google Scholar
• Tam IY , ChungLP, SuenWSet al. Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features. Clin. Cancer Res. 12(5), 1647–1653 (2006).
   PubMed Web of Science ®Google Scholar
• Riely GJ , KrisMG, RosenbaumDet al. Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma. Clin. Cancer Res. 14(18), 5731–5734 (2008).
   PubMed Web of Science ®Google Scholar
• Soda M , ChoiYl, EnomotoMet al. Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer. Nature 448(7153), 561–566 (2007).
   PubMed Web of Science ®Google Scholar
• Horn L , PaoW. EML4–ALK: honing in on a new target in non-small-cell lung cancer.J. Clin. Oncol.27(26), 4232–4235 (2009).
   PubMed Web of Science ®Google Scholar
• Koivunen JP , MermelC, ZejnullahuKet al. EML4–ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer. Clin. Cancer Res. 14(13), 4275–4283 (2008).
   PubMed Web of Science ®Google Scholar
• Wong DW , LeungEL, SoKKet al. The EML4–ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS. Cancer 115(8), 1723–1733 (2009).
   PubMed Web of Science ®Google Scholar
• Inamura K , TakeuchiK, TogashiYet al. EML4–ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset. Mod. Pathol. 22(4), 508–515 (2009).
   PubMed Web of Science ®Google Scholar
• Shaw AT , YeapBY, Mino-KenudsonMet al. Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4–ALK. J. Clin. Oncol. 27(26), 4247–4253 (2009).
   PubMed Web of Science ®Google Scholar
• Kwak EL , BangYJ, CamidgeDRet al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N. Engl. J. Med. 363(18), 1693–1703 (2010)
   PubMed Web of Science ®Google Scholar
• Le Calvez F , MukeriaA, HuntJDet al. TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers. Cancer Res. 65(12), 5076–5083 (2005).
   PubMed Web of Science ®Google Scholar
• Husgafvel-Pursiainen K , BoffettaP, KannioAet al. p53 mutations and exposure to environmental tobacco smoke in a multicenter study on lung cancer. Cancer Res. 60(11), 2906–2911 (2000).
   PubMed Web of Science ®Google Scholar
• Hwang SJ , ChengLS, LozanoG, AmosCI, GuX, StrongLC. Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking, and cancer risk.Hum. Genet.113(3), 238–243 (2003).
   PubMed Web of Science ®Google Scholar
• Gealy R , ZhangL, SiegfriedJM, LuketichJD, KeohavongP. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.Cancer Epidemiol. Biomarkers Prev.8(4 Pt 1), 297–302 (1999).
   PubMed Web of Science ®Google Scholar
• Toyooka S , TsudaT, GazdarAF. The TP53 gene, tobacco exposure, and lung cancer.Hum. Mutat.21(3), 229–239 (2003).
   PubMed Web of Science ®Google Scholar
• Subramanian J , GovindanR. Molecular genetics of lung cancer in people who have never smoked.Lancet Oncol.9(7), 676–682 (2008).
   PubMed Web of Science ®Google Scholar
• Hainaut P , PfeiferGP. Patterns of p53 G – >T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke.Carcinogenesis22(3), 367–374 (2001).
   PubMed Web of Science ®Google Scholar
• Cappuzzo F , Varella-GarciaM, ShigematsuHet al. Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients. J. Clin. Oncol. 23(22), 5007–5018 (2005).
   PubMed Web of Science ®Google Scholar
• Tomizawa K , SudaK, OnozatoRet al. Prognostic and predictive implications of HER2/ERBB2/neu gene mutations in lung cancers. Lung Cancer (2011) (Epub ahead of print).
   Google Scholar
• Digel W , LubbertM. DNA methylation disturbances as novel therapeutic target in lung cancer: preclinical and clinical results.Crit. Rev. Oncol. Hematol.55(1), 1–11 (2005).
   PubMed Web of Science ®Google Scholar
• Bowman RV , YangIA, SemmlerAB, FongKM. Epigenetics of lung cancer.Respirology11(4), 355–365 (2006).
   PubMed Web of Science ®Google Scholar
• Toyooka S , MaruyamaR, ToyookaKOet al. Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer. Int. J. Cancer 103(2), 153–160 (2003).
   PubMed Web of Science ®Google Scholar
• Wang YC , LuYP, TsengRCet al. Inactivation of hMLH1 and hMSH2 by promoter methylation in primary non-small cell lung tumors and matched sputum samples. J. Clin. Invest. 111(6), 887–895 (2003).
   PubMed Web of Science ®Google Scholar
• Kim DH , NelsonHH, WienckeJKet al. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res. 61(8), 3419–3424 (2001).
   PubMed Web of Science ®Google Scholar
• Liu Y , LanQ, SiegfriedJM, LuketichJD, KeohavongP. Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patients.Neoplasia8(1), 46–51 (2006).
   PubMed Web of Science ®Google Scholar
• Toh CK , GaoF, LimWTet al. Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity. J. Clin. Oncol. 24(15), 2245–2251 (2006).
   PubMed Web of Science ®Google Scholar
• Shimizu H , TominagaS, NishimuraM, UrataA. Comparison of clinico-epidemiological features of lung cancer patients with and without a history of smoking.Jpn J. Clin. Oncol.14(4), 595–600 (1984).
   PubMed Web of Science ®Google Scholar
• Nordquist LT , SimonGR, CantorA, AlbertsWM, BeplerG. Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung.Chest126(2), 347–351 (2004).
   PubMed Web of Science ®Google Scholar
• Toh CK , WongEH, LimWTet al. The impact of smoking status on the behavior and survival outcome of patients with advanced non-small cell lung cancer: a retrospective analysis. Chest 126(6), 1750–1756 (2004).
   PubMed Web of Science ®Google Scholar
• Tammemagi CM , Neslund-DudasC, SimoffM, KvaleP. Smoking and lung cancer survival: the role of comorbidity and treatment.Chest125(1), 27–37 (2004).
   PubMed Web of Science ®Google Scholar
• Herbst RS , PragerD, HermannRet al. TRIBUTE: a Phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer. J. Clin. Oncol. 23(25), 5892–5899 (2005).
   PubMed Web of Science ®Google Scholar
• Tsao AS , LiuD, LeeJJ, SpitzM, HongWK. Smoking affects treatment outcome in patients with advanced non-small cell lung cancer.Cancer106(11), 2428–2436 (2006).
   PubMed Web of Science ®Google Scholar
• Scagliotti GV , ParikhP, Von PawelJet al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J. Clin. Oncol. 26(21), 3543–3551 (2008).
   PubMed Web of Science ®Google Scholar
• Thatcher N , ChangA, ParikhPet al. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer). Lancet 366(9496), 1527–1537 (2005).
   PubMed Web of Science ®Google Scholar
• Mok TS , WuYL, ThongprasertSet al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N. Engl. J. Med. 361(10), 947–957 (2009).
   PubMed Web of Science ®Google Scholar
• Shepherd FA , Rodrigues PereiraJ, CiuleanuTet al. Erlotinib in previously treated non-small-cell lung cancer. N. Engl. J. Med. 353(2), 123–132 (2005).
   PubMed Web of Science ®Google Scholar
• Gatzemeier U , PluzanskaA, SzczesnaAet al. Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: the Tarceva Lung Cancer Investigation Trial. J. Clin. Oncol. 25(12), 1545–1552 (2007).
   PubMed Web of Science ®Google Scholar
• Balak MN , GongY, RielyGJet al. Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitors. Clin. Cancer Res. 12(21), 6494–6501 (2006).
   PubMed Web of Science ®Google Scholar
• Bean J , RielyGJ, BalakMet al. Acquired resistance to epidermal growth factor receptor kinase inhibitors associated with a novel T854A mutation in a patient with EGFR-mutant lung adenocarcinoma. Clin. Cancer Res. 14(22), 7519–7525 (2008).
   PubMed Web of Science ®Google Scholar
• Engelman JA , ZejnullahuK, MitsudomiTet al. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science 316(5827), 1039–1043 (2007).
   PubMed Web of Science ®Google Scholar
• Sos ML , KokerM, WeirBAet al. PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFR. Cancer Res. 69(8), 3256–3261 (2009).
   PubMed Web of Science ®Google Scholar
• Guix M , FaberAC, WangSEet al. Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins. J. Clin. Invest. 118(7), 2609–2619 (2008).
   PubMed Web of Science ®Google Scholar
• Pirker R , PereiraJR, SzczesnaAet al. Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised Phase III trial. Lancet 373(9674), 1525–1531 (2009).
   PubMed Web of Science ®Google Scholar
• Khambata-Ford S , HarbisonCT, HartLLet al. Analysis of potential predictive markers of cetuximab benefit in BMS099, a Phase III study of cetuximab and first-line taxane/carboplatin in advanced non-small-cell lung cancer. J. Clin. Oncol. 28(6), 918–927 (2010).
   PubMed Web of Science ®Google Scholar
• Truong T , HungRJ, AmosCIet al. Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J. Natl Cancer Inst. 102(13), 959–971 (2010).
   PubMedGoogle Scholar
• Amos CI , PinneySM, LiYet al. A susceptibility locus on chromosome 6q greatly increases lung cancer risk among light and never smokers. Cancer Res. 70(6), 2359–2367 (2010).
   PubMed Web of Science ®Google Scholar
• Pershagen G , WallS, TaubeA, LinnmanL. On the interaction between occupational arsenic exposure and smoking and its relationship to lung cancer.Scand. J. Work Environ. Health7(4), 302–309 (1981).
   PubMed Web of Science ®Google Scholar
• Bryant A , CerfolioRJ. Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer.Chest132(1), 185–192 (2007).
   PubMed Web of Science ®Google Scholar
• Kenfield SA , WeiEK, StampferMJ, RosnerBA, ColditzGA. Comparison of aspects of smoking among the four histological types of lung cancer.Tob. Control17(3), 198–204 (2008).
   PubMed Web of Science ®Google Scholar
• Lee YJ , ShimHS, KangYAet al. Dose effect of cigarette smoking on frequency and spectrum of epidermal growth factor receptor gene mutations in Korean patients with non-small cell lung cancer. J. Cancer Res. Clin. Oncol. 136(12), 1937–1944 (2010).
   PubMed Web of Science ®Google Scholar
• Eberhard DA , JohnsonBE, AmlerLCet al. Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib. J. Clin. Oncol. 23(25), 5900–5909 (2005).
   PubMed Web of Science ®Google Scholar
• Massarelli E , Varella-GarciaM, TangXet al. KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer. Clin. Cancer Res. 13(10), 2890–2896 (2007).
   PubMed Web of Science ®Google Scholar

Websites

• World Cancer Research Fund International. Food, nutrition, physical activity, and the prevention of cancer. a global perspective. (2007) http://eprints.ucl.ac.uk/4841/4841.pdf
   Google Scholar
• Clinical Trials, NIH http://clinicaltrials.gov/
   Google Scholar